.jpg?itok=W6nsHDXV)
Company search
.jpg?h=140710cd&itok=Ya02teri)
Biotechnology & Healthcare: a sector on the mend?
What’s the prognosis for biotech and healthcare companies? How will the US election impact the sector, and could we see a recovery later this year?
Overview
Performance
Portfolio
Dividends
Charges
Gearing
Research
Announcements
Management
Documents
Invest
Research
Please note that this research may have been paid for by the investment company. Any opinions and ratings are not endorsed by the AIC.
Related articles
Could AI “serve as a catalyst driving the biotech industry into the future”?
Biotechnology & Healthcare investment companies comment on the “bright” outlook for the sector.
Related videos
Monthly roundup: the budget’s impact, DGN's strategic review and our podcasts & results highlights
Jo Groves, Ryan Lightfoot-Aminoff and David Brenchley from Kepler Trust Intelligence discuss the most notable news and interviews in the investment trust world in October.
Biotechnology & Healthcare: what are the challenges of investing in the sector?
Annabel Brodie-Smith asks managers about the challenges of investing in the Biotechnology & Healthcare sector.
Biotechnology & Healthcare: where are you finding opportunities?
A panel of Biotechnology & Healthcare managers discuss where they are currently finding opportunities.
Kepler Trust Intelligence Themes for your ISA in 2024 - Bellevue Healthcare
For this ISA season we hear from fifteen fund managers in a series of webinars throughout March examining a wide range of strategies and themes to meet the needs of a diversified portfolio…
Related Industry News
Bellevue Healthcare U-turns on plan to scrap redemption facility
Global small-cap healthcare portfolio forced into ‘embarrassing’ retreat on plan to replace annual redemption facility its board believed could threaten the fund’s viability.
Bellevue Healthcare to replace annual redemption with performance related tender
Bellevue Healthcare (BBH) says that, following the redemption requests in relation to its annual redemption facility that saw some 36% of shareholders...
QuotedData’s morning briefing 29 November 2024 – BBH
In QuotedData’s morning briefing 29 November 2024: Bellevue Healthcare (BBH) has announced the redemption price for its annual redemption opportunity ...
James Carthew: If Trump avoids healthcare pain, now’s a good time to buy
Donald Trump’s provocative healthcare appointments have caused uncertainty for drugs developers but the outlook remains positive once the political noise abates.
Investment company news brought to you by Citywire Financial Publishers Limited
and QuotedData by Marten & Co.
Data provided by Morningstar.
Company documents provided by FE fundinfo.
